Cairo – Mubasher: Nile Pharmaceuticals and Chemical Industries Company announced that its Extraordinary General Assembly meeting will be held on Sunday, November 15, 2026.
The company stated in a disclosure to the Egyptian Exchange today that the General Assembly will consider approving the increase of issued capital from EGP 500 million to EGP 1 billion, with an increase of EGP 500 million distributed over 50 million shares at a nominal value of EGP 10 per share.
It added that the increase is cash-funded by inviting existing shareholders to subscribe to the capital increase, with the trading of pre-emptive subscription rights and without issuance fees, based on the Financial Regulatory Authority's approval to publish the disclosure report.
It also pointed out that the assembly will discuss the detailed study on the uses of the increase proceeds, its justifications, and expected returns, in addition to authorizing the Board of Directors to amend Articles 6 and 7 of the company's Articles of Association in light of the subscription results.
